Conference “Controlled Release meets BioBarriers” will take place from March 3 to 6, 2026, in Saarbrücken

Significant progress for active substance against neglected tropical diseases developed at the DZIF, UKB, HIPS and HZI

From rare bacteria to the basis for new drugs

Research partnership aims to deliver new scientific insights into skin care and maintaining healthy skin

Rolf Müller becomes a member of the scientific advisory board of the European partnership OHAMR

HIPS researcher explains how artificial intelligence supports the development of new drugs